Literature DB >> 11733561

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells.

D A Dixon1, N D Tolley, P H King, L B Nabors, T M McIntyre, G A Zimmerman, S M Prescott.   

Abstract

Cyclooxygenase-2 (COX-2) expression is normally tightly regulated. However, constitutive overexpression plays a key role in colon carcinogenesis. To understand the molecular nature of enhanced COX-2 expression detected in colon cancer, we examined the ability of the AU-rich element-containing (ARE-containing) 3' untranslated region (3'UTR) of COX-2 mRNA to regulate rapid mRNA decay in human colon cancer cells. In tumor cells displaying enhanced growth and tumorigenicity that is correlated with elevated COX-2, vascular endothelial growth factor (VEGF), and IL-8 protein levels, the corresponding mRNAs were transcribed constitutively and turned over slowly. The observed mRNA stabilization is owing to defective recognition of class II-type AREs present within the COX-2, VEGF, and IL-8 3'UTRs; c-myc mRNA, containing a class I ARE decayed rapidly in the same cells. Correlating with cellular defects in mRNA stability, the RNA-binding of trans-acting cellular factors was altered. In particular, we found that the RNA-stability factor HuR binds to the COX-2 ARE, and overexpression of HuR, as detected in tumors, results in elevated expression of COX-2, VEGF, and IL-8. These findings demonstrate the functional significance rapid mRNA decay plays in controlling gene expression and show that dysregulation of these trans-acting factors can lead to overexpression of COX-2 and other angiogenic proteins, as detected in neoplasia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733561      PMCID: PMC200983          DOI: 10.1172/JCI12973

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

Review 1.  Cyclooxygenase-independent actions of cyclooxygenase inhibitors.

Authors:  I Tegeder; J Pfeilschifter; G Geisslinger
Journal:  FASEB J       Date:  2001-10       Impact factor: 5.191

2.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer.

Authors:  H Sano; Y Kawahito; R L Wilder; A Hashiramoto; S Mukai; K Asai; S Kimura; H Kato; M Kondo; T Hla
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

3.  Cytokine messenger RNA stability is enhanced in tumor cells.

Authors:  H J Ross; N Sato; Y Ueyama; H P Koeffler
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

4.  Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation.

Authors:  A Ristimäki; S Garfinkel; J Wessendorf; T Maciag; T Hla
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

5.  Altered eicosanoid levels in human colon cancer.

Authors:  B Rigas; I S Goldman; L Levine
Journal:  J Lab Clin Med       Date:  1993-11

6.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

Authors:  M Tsujii; R N DuBois
Journal:  Cell       Date:  1995-11-03       Impact factor: 41.582

7.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

Authors:  C E Eberhart; R J Coffey; A Radhika; F M Giardiello; S Ferrenbach; R N DuBois
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

8.  Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

Authors:  M Tsujii; S Kawano; S Tsuji; H Sawaoka; M Hori; R N DuBois
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

9.  Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.

Authors:  S L Kargman; G P O'Neill; P J Vickers; J F Evans; J A Mancini; S Jothy
Journal:  Cancer Res       Date:  1995-06-15       Impact factor: 12.701

10.  Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors.

Authors:  R N DuBois; A Radhika; B S Reddy; A J Entingh
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  169 in total

1.  ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR.

Authors:  Michael Kullmann; Ulrich Göpfert; Basile Siewe; Ludger Hengst
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

2.  mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells.

Authors:  Federico Bolognani; Anne-Isabelle Gallani; Lena Sokol; David S Baskin; Nicole Meisner-Kober
Journal:  J Neurooncol       Date:  2011-09-21       Impact factor: 4.130

Review 3.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

4.  Roles of AUF1 isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by RNA interference.

Authors:  Ines Raineri; Daniel Wegmueller; Brigitte Gross; Ulrich Certa; Christoph Moroni
Journal:  Nucleic Acids Res       Date:  2004-02-19       Impact factor: 16.971

5.  Global analysis of HuR-regulated gene expression in colon cancer systems of reducing complexity.

Authors:  Isabel López de Silanes; Jinshui Fan; Craig J Galbán; Richard G Spencer; Kevin G Becker; Myriam Gorospe
Journal:  Gene Expr       Date:  2004

6.  The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.

Authors:  Lisa E Young; Ashleigh E Moore; Lena Sokol; Nicole Meisner-Kober; Dan A Dixon
Journal:  Mol Cancer Res       Date:  2011-11-02       Impact factor: 5.852

7.  The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.

Authors:  F F Blanco; M Jimbo; J Wulfkuhle; I Gallagher; J Deng; L Enyenihi; N Meisner-Kober; E Londin; I Rigoutsos; J A Sawicki; M V Risbud; A K Witkiewicz; P A McCue; W Jiang; H Rui; C J Yeo; E Petricoin; J M Winter; J R Brody
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

8.  Cyclooxygenase-2 transactivates the epidermal growth factor receptor through specific E-prostanoid receptors and tumor necrosis factor-alpha converting enzyme.

Authors:  Mazin A Al-Salihi; Scott C Ulmer; Thao Doan; Cory D Nelson; Tracy Crotty; Stephen M Prescott; Diana M Stafforini; Matthew K Topham
Journal:  Cell Signal       Date:  2007-05-23       Impact factor: 4.315

9.  Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1).

Authors:  Gareth Sully; Jonathan L E Dean; Robin Wait; Lesley Rawlinson; Tomas Santalucia; Jeremy Saklatvala; Andrew R Clark
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

10.  Integrin α3β1 controls mRNA splicing that determines Cox-2 mRNA stability in breast cancer cells.

Authors:  Sita Subbaram; Scott P Lyons; Kimberly B Svenson; Sean L Hammond; Lorena G McCabe; Sridar V Chittur; C Michael DiPersio
Journal:  J Cell Sci       Date:  2014-01-16       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.